These constraints of the BTNX NTS are very appropriate, as we observed e.g. etodesnitazene to have a similar in vitro potency and efficacy as fentanyl [seven, 13] and as it might probably give PWUD a Untrue sense of protection. In addition, the detectability of nitazene analogues in drug samples may very well be impacted by solubility issues, as hi